Bacterial colicin-immunity protein protein purification system
US-2024417426-A1 · Dec 19, 2024 · US
US10501745B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10501745-B2 |
| Application number | US-201615563750-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2016 |
| Priority date | Apr 2, 2015 |
| Publication date | Dec 10, 2019 |
| Grant date | Dec 10, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the vector, and a method for producing a target protein using the promoter.
Opening claim text (preview).
The invention claimed is: 1. An isolated nucleic acid molecule having a promoter activity, wherein the isolated nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO: 1. 2. A target protein expression cassette comprising the isolated nucleic acid molecule having a promoter activity of claim 1 and a gene encoding a target protein. 3. A recombinant vector comprising the isolated nucleic acid molecule of claim 1 or the target protein expression cassette of claim 2 . 4. The recombinant vector of claim 3 , wherein the target protein is a psicose-3-epimeras. 5. A method for producing psicose, comprising: (a) culturing the microorganism introduced with the vector of claim 4 ; and (b) reacting the cultured microorganism with fructose to produce psicose. 6. A recombinant microorganism introduced with the vector of claim 4 . 7. The recombinant microorganism of claim 6 , wherein the microorganism is a microorganism of the genus Corynebacterium. 8. The recombinant microorganism of claim 7 , wherein the microorganism of the genus Corynebacterium is Corynebacterium glutamicum or Corynebacterium ammoniagenes. 9. The recombinant microorganism of claim 6 , wherein the microorganism is a microorganism of the genus Escherichia. 10. The recombinant microorganism of claim 9 , wherein the microorganism of the genus Escherichia is Escherichia coli. 11. A method for producing a target protein, comprising: (a) culturing the recombinant microorganism of claim 6 in a medium to produce a target protein; and (b) recovering the produced target protein from the cultured microorganism or the medium. 12. A recombinant microorganism introduced with the vector of claim 3 . 13. The recombinant microorganism of claim 12 , wherein the microorganism is a microorganism of the genus Corynebacterium. 14. The recombinant microorganism of claim 13 , wherein the microorganism of the genus Corynebacterium is Corynebacterium glutamicum or Corynebacterium ammoniagenes. 15. The recombinant microorganism of claim 12 , wherein the microorganism is a microorganism of the genus Escherichia. 16. The recombinant microorganism of claim 15 , wherein the microorganism of the genus Escherichia is Escherichia coli. 17. A method for producing a target protein, comprising: (a) culturing the recombinant microorganism of claim 12 in a medium to produce the target protein; and (b) recovering the produced target protein from the cultured microorganism or the medium.
having a known sequence of two or more amino acids, e.g. glutathione · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title
Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.